A detailed history of Tejara Capital LTD transactions in Chimerix Inc stock. As of the latest transaction made, Tejara Capital LTD holds 414,430 shares of CMRX stock, worth $381,275. This represents 0.13% of its overall portfolio holdings.

Number of Shares
414,430
Previous 414,430 -0.0%
Holding current value
$381,275
Previous $439 Million 17.36%
% of portfolio
0.13%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.91 - $1.26 $123,437 - $170,913
-135,646 Reduced 24.66%
414,430 $439 Million
Q4 2023

Feb 12, 2024

BUY
$0.9 - $1.06 $159,692 - $188,082
177,436 Added 47.62%
550,076 $529 Million
Q2 2023

Aug 11, 2023

SELL
$1.1 - $1.54 $21,690 - $30,367
-19,719 Reduced 5.03%
372,640 $451 Million
Q1 2023

May 12, 2023

BUY
$1.19 - $2.09 $77,977 - $136,951
65,527 Added 20.05%
392,359 $494 Million
Q4 2022

Feb 13, 2023

BUY
$1.67 - $2.35 $545,809 - $768,055
326,832 New
326,832 $608 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $80.6M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.